2021
DOI: 10.1371/journal.pgen.1009711
|View full text |Cite
|
Sign up to set email alerts
|

c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease

Abstract: Polycystic kidney disease is an inherited degenerative disease in which the uriniferous tubules are replaced by expanding fluid-filled cysts that ultimately destroy organ function. Autosomal dominant polycystic kidney disease (ADPKD) is the most common form, afflicting approximately 1 in 1,000 people. It primarily is caused by mutations in the transmembrane proteins polycystin-1 (Pkd1) and polycystin-2 (Pkd2). The most proximal effects of Pkd mutations leading to cyst formation are not known, but pro-prolifera… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 86 publications
1
9
0
Order By: Relevance
“…Our results suggest no synergetic effect of the two stresses as the addition of febrile-mimicking heat stress does not change the length of the ciliated cell but dramatically decreases the frequency of ciliated cells. Current work also extends the previous observation regarding the potential role of MAPK kinase JNK in ciliogenesis 18,19,21 , adding the context of the inflammatory response, a previously unreported role for JNK kinase. Generally, p38MAPK and JNK are activated by the MAP kinase kinase kinases (MKKKs or MAP3Ks; such as Mixed Lineage Kinases (MLKs).…”
Section: Resultssupporting
confidence: 85%
See 1 more Smart Citation
“…Our results suggest no synergetic effect of the two stresses as the addition of febrile-mimicking heat stress does not change the length of the ciliated cell but dramatically decreases the frequency of ciliated cells. Current work also extends the previous observation regarding the potential role of MAPK kinase JNK in ciliogenesis 18,19,21 , adding the context of the inflammatory response, a previously unreported role for JNK kinase. Generally, p38MAPK and JNK are activated by the MAP kinase kinase kinases (MKKKs or MAP3Ks; such as Mixed Lineage Kinases (MLKs).…”
Section: Resultssupporting
confidence: 85%
“…TNFalpha activates multiple downstream MLK targets, with p38 and JNK being among the best-characterized downstream stress kinases 17 . Moreover, JNK is involved in the ciliarelated genetic kidney polycystic disorder 18,19 and ciliogenesis in multiciliated pulmonary cells 21 , and both p38 and JNK were reported to affect atypical centrosome maturation during immune response in non-ciliated macrophages and RPE cells 7,22 . To evaluate the role of JNK and p38 on TNF-induced cilia elongation and frequency, we used a wellcharacterized small molecule JNK inhibitor SP-600125 and p38 inhibitor BIRB796 (Figure 3).…”
Section: Tnf-alpha Induces Cilia Elongation Via Mlk Signalingmentioning
confidence: 99%
“…To validate the epithelial expression of Tacstd2 predicted by single-cell RNAseq, we immuno-stained kidney tissues collected from the same cohort of animals that were used for RNA isolation in this study (Fig 4A, 4B). In addition, to see how Tacstd2 responds in more highly cystic kidneys, we examined P21 tissue collected from another study where Pkd2 was deleted in the early post-natal period by tamoxifen treatment of mothers nursing Rosa26-Cre ERT2 , Pkd2 flox/flox pups (20) (Fig 4A, 4B). We find that Tacstd2 does not stain proximal tubules in either control or Pkd2 mutant tissue but does label collecting ducts in both control and experimental kidneys (Fig 4C).…”
Section: Resultsmentioning
confidence: 99%
“…JNK phosphorylates c-jun to activate the AP-1 transcription factor which is known to play a major role in the regulation of inflammatory genes in both skin and renal fibrosis [ 75 77 ]. Active JNK is elevated in diseased kidneys and early clinical trials as well as preclinical models suggest that JNK inhibitors may have some efficacy in treating fibrotic kidney disease [ 78 , 79 ]. Active JNK is also seen in keloids and hypertrophic scars of the skin where it has been proposed as a therapeutic target [ 80 , 81 ].…”
Section: Discussionmentioning
confidence: 99%